Skip to main content
SpringerLink
Log in

Effect of Octreotide on Human Sphincter of Oddi Motility Following Liver Transplantation

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The effect of octreotide on sphincter of Oddimotility was investigated in six liver transplantpatients, employing percutaneous (through the T-tubetract) manometry. Continuous and simultaneous sphincter of Oddi and duodenal motor activities wererecorded before and for 60 min after the administrationof octreotide (100 μg subcutaneously) and after theinjection of cholecystokinin (0.02 μg/kgintravenously). With octreotide, contraction frequency andbasal pressure significantly increased (P < 0.05).This effect lasted more than 60 min, long afteroctreotide-induced duodenal migrating motor complexphase III activity had ceased. Sphincter of Oddicontraction amplitude and duration were unaffected byoctreotide. Subsequent cholecystokinin administrationtransiently reduced sphincter of Oddi basal pressure and contraction frequency. We conclude thatoctreotide significantly increases sphincter of Oddibasal pressure and contraction frequency. This effect isdistinct from octreotide induction of migrating motor complex phase III activity, persists for aprolonged period, and is inhibited bycholecystokinin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Lucey MR, Yamada T: Biochemistry and physiology of gastrointestinal somatostatin. Dig Dis Sci 34:5S–13S, 1989

    Google Scholar 

  2. Gordon P, Comi RJ, Maton PN, Go VLW: Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 110:35–50, 1989

    Google Scholar 

  3. Grossman I, Simon D: Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 85:1061–1072, 1990

    Google Scholar 

  4. Tamas G, Tulassay Z, Papp J, Paksy A, Kovanyi L, Kisfalsy S, Steczek K: Effect of somatostatin on the pancreatitis-like biochemical changes due to endoscopic pancreatography: Preliminary report. Metabolism 27:1333–1336, 1978

    Google Scholar 

  5. Tyden G, Nyberg B, Sonnefeld T, Thulin L: Effect of somatostatin on hyperamylasemia following endoscopic pancreatography. Acta Chir Scand Suppl 530:43–45, 1986

    Google Scholar 

  6. Bordas JM, Toledo V, Mondelo F, Rodes J: Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing retrograde cholangiopancreatography and endoscopic sphincterotomy. Horm Res 29:106–108, 1988

    Google Scholar 

  7. Tulassay Z, Papp J: The effect of long acting somatostatin analogue on enzyme changes after endoscopic pancreatography. Gastrointest Endosc 37:48–50, 1991

    Google Scholar 

  8. Sternlieb JM, Aronchick CA, Retig JN, Dabezies M, Saunders F, Goosenberg E, Infantolino A, Ionna S, Maislin G, Wright SH, Lipshutz WH: A multicenter randomized, controlled trial to evaluate the effect of octreotide on post-ERCP pancreatitis. Am J Gastroenterol 85:1561–1566, 1992

    Google Scholar 

  9. Binmoellar KF, Harris AG, Dumas R, Grimaldi C, Delmont JP: Does the somatostatin analogue octreotide protect against ERCP-induced pancreatitis? Gut 33:1129–1133, 1992

    Google Scholar 

  10. Arcidiacono R, Gambitta P, Rossi A, Grosso C, Bini M, Zanasi G: The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 26:715–718, 1994

    Google Scholar 

  11. Ho KY, Weissberger AJ, Marbach P, Lazarus L: Therapeutic efficacy of somatostatin analog SMS 201–995 (octreotide) in acromegaly: Effects of dose and frequency and long-term safety. Ann Intern Med 112:173–181, 1990

    Google Scholar 

  12. Krejs GJ, Orci L, Conlon JM, Ravazzola M, Davis GR, Raskin P, Collins SM, McCarthy DM, Baetans D, Rubenstein A, Aldor TAM, Unger RH: Somatostatinoma syndrome. Biochemical, morphologic, and clinical features. N Engl J Med 301:285–292, 1979

    Google Scholar 

  13. Dancygier H, Klein U, Leuschner U, Hubner K, Classen M: Somatostatin-containing cells in the extrahepatic biliary tract. Gastroenterology 85:892–896, 1984

    Google Scholar 

  14. Binmoellar KF, Dumas R, Harris AG, Delmont JP: Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci 37:773–777, 1992

    Google Scholar 

  15. Peeters TL, Janssens J, Vantrappen GR: Somatostatin and the interdigestive migrating motor complex in man. Regul Pept 5:209–217, 1983

    Google Scholar 

  16. Worthley CS, Baker PA, Iannos J, Saccone GTP, Toouli J: Human fasting and postprandial sphincter of Oddi motility. Br J Surg 76:709–714, 1989

    Google Scholar 

  17. Richards RD, Yeaton P, Shaffer HA, Pambianco DJ, Pruett TL, Stevenson WC, Mittal RK, McCallum R: Human sphincter of Oddi motility and cholecystokinin response following liver transplantation. Dig Dis Sci 38:462–468, 1993

    Google Scholar 

  18. Redfern JS, Fortuner WJ: Octreotide-associated biliary tract dysfunction and gallstone formation: Pathophysiology and management. Am J Gastroenterol 90:1042–1052, 1995

    Google Scholar 

  19. Adami GF, Leandri P, Sarles JC: Action de la somatostatine sur le sphincter d'Oddi du lapin “in vivo.” Inter-relations somatostatine-cholecystokinine. Gastroenterol Clin Biol 10:108–111, 1986

    Google Scholar 

  20. Ahrendt SA, Ahrendt GM, Lillemore KD, Pitt HA: Effect of octreotide on sphincter of Oddi and gallbladder motility in prairie dogs. Am J Physiol G909–G914, 1992

  21. Sarles JC, Devaux MA, Echinard C, Castignini A: Action of cholecystokinin and caerulein on the rabbit sphincter of Oddi. Digestion 14:415–423, 1976

    Google Scholar 

  22. Toouli J, Dodds WJ, Honda R, Sarna S, Hogan WJ, Komarowski RA, Linehan JH, Arndorfer RC: Motor function of the opossum sphincter of Oddi. J Clin Invest 71:208–220, 1983

    Google Scholar 

  23. Toouli J: Sphincter of Oddi motility. Br J Surg 71:251–256, 1984

    Google Scholar 

  24. Torsoli A: Physiology of the human sphincter of Oddi. Endoscopy 20:166–170, 1988

    Google Scholar 

  25. Dodds WJ, Hogan WJ, Geenen JE: Perspectives about function of the sphincter of Oddi. Gastroenterol Int 2:229–233, 1989

    Google Scholar 

  26. Cattau EL Jr, Johnson DA, Benjamen SB, Geenan JE, Hogan WJ: Sphincter of Oddi manometry: A survey of methodology, complications and clinical application. Gastrointest Endosc 34:A185, 1988

    Google Scholar 

  27. King CE, Kalvaria I, Sninsky CA: Pancreatitis due to endoscopic manometry: Proceed with caution. Gastroenterology 94:A227, 1988

    Google Scholar 

  28. Rolny P, Anderberg B, Ihse I, Lindstrom E, Olaison G Arvill A: Pancreatitis after sphincter of Oddi manometry. Gut 31:821–824, 1990

    Google Scholar 

  29. Sherman S, Troiano FP, Hawes RH, Lehman GA: Sphincter of Oddi manometry: Decreased risk of clinical pancreatitis with the use of a modified catheter. Gastrointest Endosc 36:462–466, 1990

    Google Scholar 

  30. Sherman S, Hawes RH, Troiano FP, Lehman GA: Pancreatitis following bile duct sphincter of Oddi manometry: Utility of the aspirating catheter. Gastrointest Endosc 38:347–350, 1992

    Google Scholar 

  31. Warzee PL, Ghilain JM, Deprez PH, Dive CH: Effect of somatostatin on the motor activity of the sphincter of Oddi: Simultaneous video manometric and endoscopic study. Gastroenterology 102:A337, 1992

    Google Scholar 

  32. Cherubini M, Baxa P, Mattiussi A, Dell'Antonio A, Cataldo R, Ginonneschi U: Normal function and motor disorders of the sphincter of Oddi revealed by electronic flowgraphy. Surg Res Commun 1:215–226, 1987

    Google Scholar 

  33. Hogan WJ, Geenen JE, Dodds WJ: Dysmotility disturbances of the biliary tract: Classification, diagnosis, and treatment. Semin Liver Dis 4:302–310, 1987

    Google Scholar 

  34. Toouli J, Bushell M, Stevenson G, et al: Gallbladder emptying in man related to fasting duodenal migratory motor contractions. Aust NZ J Surg 56:625–629, 1986

    Google Scholar 

  35. Kohler W, Begliner C, Dettwiler S, et al: Effect of a new somatostatin analogue on pancreatic function in healthy volunteers. Pancreas 1:154–159, 1986

    Google Scholar 

  36. Lembocke B, Creutzfeldt W, Schlesser S, et al: Effect of the somatostatin analogue sandostatin (SMS 201–995) on gastrointestinal, pancreatic, and biliary function and hormone release in normal men. Digestion 36:108–124, 1987

    Google Scholar 

  37. Gullo L, Priori P, Scarpignato C, et al: Effect of somatostatin-14 on pure human pancreatic secretion. Dig Dis Sci 32:1065–1070, 1987

    Google Scholar 

Download references

Authors
  1. Frederick H. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard John Sears
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Kendall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Timothy L. Pruett
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hubert A. Shaffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paul Yeaton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weber, F.H., Sears, R.J., Kendall, B. et al. Effect of Octreotide on Human Sphincter of Oddi Motility Following Liver Transplantation. Dig Dis Sci 42, 1168–1175 (1997). https://doi.org/10.1023/A:1018885519918

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018885519918

Search

Navigation